Charizard

SM Black Star Promos · #SM158 · Promo

Live NM ask

€187.49

↑ 12.6% 30D

PSA 9

–

no graded data

PSA 10

–

no graded data

Composite

4.4

Cardmarket (EUR) →eBay (US) →

Buy range—Buy range unavailable

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

4.4

SCORE / 10

Liquidity

0.0

Scarcity

—

Era potential

2.8

Friction

1.5

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10

PSA 9

PSA 8

Total graded

No PSA pop data on file for this card yet.

OVERVIEW

Investment summary

SM Black Star Promos's Charizard (#SM158) currently trades at €187.49 in the raw market. Its 30-day price movement has appreciated (+12.6%). By market value it ranks #5 of 251 in SM Black Star Promos — the 100th percentile of the set. Read together, a top-tier ranking in SM Black Star Promos alongside rising 30-day momentum frames where Charizard sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.